Skip to Main Content
Wyss Institute
Menu
Search Site
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Search
News search results
10 Results for ''
Translation News
Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
October 2, 2024
Press Release
“Suspended animation” drug could aid organ transplantation and survival from traumatic injury
September 24, 2024
Community
Eliz Amar Lewis on Using Many Tools to Fight a Sophisticated Disease
September 24, 2024
Community
Preventing pollution with bioinspired solutions
September 19, 2024
Community
Wyss Institute and Dr. Milad Alucozai Launch “Code to Cure” Newsletter
September 18, 2024
Press Release
Wyss Institute team selected by DARPA-SHIELD program to develop first-of-its-kind biologically engineered broad-spectrum antimicrobial therapeutic
September 16, 2024
Press Release
Alzheimer’s drug may someday help save lives by inducing a state of “suspended animation”
August 22, 2024
Community
Vinny Chandran Suja on Making Backpacks More Reliable and Predictable
August 20, 2024
Press Release
Wyss Institute promotes Natalie Artzi to its Core Faculty and appoints Di Feng as an Associate Faculty member
August 12, 2024
Press Release
3D-printed blood vessels bring artificial organs closer to reality
August 7, 2024
Close search results
close menu
Who We Are
About
How We Work
How We Collaborate
Team
Careers
Contact
Our Work
Technologies
Impact Report
Business Insider
Publications
Collaborations
Brain Targeting Program
Collaborative Fund Alliance
Diagnostics Accelerator
i3 Center
Northpond Labs Alliance
Newsroom
News
Press Resources
Multimedia
Events
Give
Close menu
